Trial Profile
Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C (Fibrosar)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Mar 2021
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Hepatic fibrosis; Hepatitis C
- Focus Therapeutic Use
- 12 May 2015 New trial record